Breaking News

WuXi AppTec’s Lab Testing Division Expands in Suzhou

Increases toxicology capacity by 80% to execute full-service preclinical and clinical safety assessments for biologics and small molecules

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi AppTec’s Lab Testing Division (LTD) has expanded the Suzhou safety assessment facility by increasing toxicology capacity by 80% to meet global preclinical testing needs and to enable the acceleration of development timelines. With the expansion, the toxicology facility will cover an area of 580,000 square feet and execute full-service preclinical and clinical stage safety assessments for biologic and small molecule drugs. “By investing in the toxicology facility, we are answering t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters